(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ABCLONAL TECHNOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ABCLONAL TECHNOLOGY

ST13

US500000086837812

Class

1, 5, 42

Filing

86837812

Registration

5030497

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

04/16/2026

Trademark type

Combined

Nice classes

1, 5, 42

Filing date

12/03/2015

Registration date

08/30/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/30/2026

Last transaction

04/16/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/26/2013

First use in commerce

08/26/2013

Drawing code

3

Owner type

03

Owner location

Wuhan, CN

Examiner

COLEMAN, CIMMERIAN

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a design portion and a literal portion. The design portion is on the left side, including a triangle, a solid hexagon, and a hexagon arranged concentrically. The literal portion is on the right side, including the wording "ABclonal Technology".

Holders and representatives

Holders

Wuhan ABclonal Biotechnology Co., Ltd

Representatives

Kevin L. Russell CHERNOFF VILHAUER LLP

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemicalspolyclonal antibodies for in vitro scientific or research use; diagnostic kits consisting of polyclonal antibodiesbuffersreagents for scientific and research use; biochemicalspolyclonal antibodies for the detection of antigens; diagnostic kits consisting of polyclonal antibodiesbuffersreagents for use in disease testing; biochemicalscustom polyclonal antibodies specifically recognizing antigens provided by customer; biochemicalsmonoclonal antibodies for in vitro scientific or research use; diagnostic kits consisting of monoclonal antibodiesbuffersreagents for scientific and research use; biochemicalsmonoclonal antibodies for the detection of antigens; biochemicalscustom monoclonal antibodies specifically recognizing antigens provided by customer; Enzyme-linked immunosorbent assay kits comprised of assays and reagents for scientific and research use; chemical reagentsrecombinant protein for scientific and research use; chemicalscustom recombinant proteins manufactured for others; biochemical kits consisting of recombinant proteinsbuffersreagents for scientific and research use

Class 5

Diagnostic kits consisting of monoclonal antibodiesbuffersreagents for use in disease testing; Diagnostic kits consisting of recombinant proteinsbuffersreagents for use in disease testing

Class 42

custom design and development of polyclonal antibodies specifically recognizing an antigen; custom design and development of kits consisting polyclonal antibodies specifically recognizing an antigenbuffersreagents for scientific and research use; custom design and development of kits consisting of polyclonal antibodies specifically recognizing an antigenbuffersreagents for detection of the antigen; custom design and development of monoclonal antibodies specifically recognizing an antigen; custom design and development of kits consisting of monoclonal antibodies specifically recognizing an antigenbuffersreagents for scientific and research use; custom design and development of kits consisting of monoclonal antibodies specifically recognizing an antigenbuffersreagents for detection of the antigen; custom design and development of recombinant proteins for others; Custom design and development of enzyme-linked immunosorbent assay kits consisting of polyclonal antibodies recognizing an antigenbuffersreagents; Custom design and development of enzyme-linked immunosorbent assay kits consisting of monoclonal antibodies recognizing an antigenbuffersreagents; Custom design and development of recombinant proteins for scientific and research use; Custom design and development of kits consisting of recombinant proteinsbuffersreagents for scientific and research use; Custom design and development of diagnostic kits consisting of recombinant proteinsbuffersreagents for use in disease testing

Publications

History of USPTO decisions and trademark events.

29 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/14/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/14/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/14/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/30/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/30/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/30/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/30/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

10/27/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/30/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/31/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/31/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/14/2021

E815

TEAS SECTION 8 & 15 RECEIVED

09/13/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/30/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/30/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/14/2016

PUBO

PUBLISHED FOR OPPOSITION

06/14/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/25/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/04/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/03/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/03/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/05/2016

GNRT

NON-FINAL ACTION E-MAILED

04/05/2016

CNRT

NON-FINAL ACTION WRITTEN

04/05/2016

DOCK

ASSIGNED TO EXAMINER

03/22/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/09/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/08/2015

NWAP

NEW APPLICATION ENTERED

12/07/2015

Continuous trademark protection

Get notified about every new filing that threatens ABCLONAL TECHNOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.